Related Experiment Video
Updated: Mar 16, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
TLR4-Dependent Claudin-1 Internalization and Secretagogue-Mediated Chloride Secretion Regulate Irinotecan-Induced
Hannah R Wardill1,2, Joanne M Bowen3, Ysabella Z A Van Sebille3
1Discipline of Anatomy and Pathology, School of Medicine, University of Adelaide, Adelaide, South Australia, Australia. hannah.wardill@adelaide.edu.au.
Abstract:
We have previously shown increased intestinal permeability, to 4-kDa FITC-dextran, in BALB/c mice treated with irinotecan. Importantly, genetic deletion of Toll-like receptor 4 (TLR4; Tlr4-/-) protected against loss of barrier function, indicating that TLR4 is critical in tight junction regulation. The current study aimed (i) to determine the molecular characteristics of intestinal tight junctions in wild-type and Tlr4-/- BALB/c mice and (ii) to characterize the secretory profile of the distal colon. Forty-two female wild-type and 42 Tlr4-/- BALB/c mice weighing between 18 and 25 g received a single 270 mg/kg [intraperitoneal (i.p.)] dose of irinotecan hydrochloride or vehicle control and were killed at 6, 24, 48, 72, and 96 hours. The secretory profile of the distal colon, following carbachol and forksolin, was assessed using Ussing chambers at all time points. Tight junction integrity was assessed at 24 hours, when peak intestinal permeability and diarrhea were reported, using immunofluorescence, Western blotting, and RT-PCR. Irinotecan caused internalization of claudin-1 with focal lesions of ZO-1 and occludin proteolysis in the ileum and colon of wild-type mice. Tlr4-/- mice maintained phenotypically normal tight junctions. Baseline conductance, a measure of paracellular permeability, was increased in irinotecan-treated wild-type mice at 24 hours (53.19 ± 6.46 S/cm2; P = 0.0008). No change was seen in Tlr4-/- mice. Increased carbachol-induced chloride secretion was seen in irinotecan-treated wild-type and Tlr4-/- mice at 24 hours (wild-type: 100.35 ± 18.37 μA/cm2; P = 0.022; Tlr4-/-: 102.72 ± 18.80 μA/cm2; P = 0.023). Results suggest that TLR4-dependent claudin-1 internalization and secondary anion secretion contribute to irinotecan-induced diarrhea. Mol Cancer Ther; 15(11); 2767-79. ©2016 AACR.
Insights
Toll-like receptor 4 (TLR4) plays a key role in irinotecan-induced intestinal damage. Genetic deletion of TLR4 protects mice from irinotecan
Area of Science:
- Gastroenterology
- Immunology
- Pharmacology
Background:
- Irinotecan chemotherapy can cause intestinal injury and diarrhea.
- Toll-like receptor 4 (TLR4) has been implicated in irinotecan-induced intestinal permeability.
- The precise role of TLR4 in regulating intestinal tight junctions and secretion during irinotecan treatment requires further elucidation.
Purpose of the Study:
- To investigate the molecular characteristics of intestinal tight junctions in wild-type and Tlr4-deficient (Tlr4-/-) mice treated with irinotecan.
- To characterize the secretory profile of the distal colon in response to irinotecan in a Tlr4-dependent manner.
- To elucidate the contribution of TLR4 to irinotecan-induced diarrhea.
Main Methods:
- BALB/c mice (wild-type and Tlr4-/-) were administered irinotecan or vehicle.
- Intestinal permeability was assessed using FITC-dextran.
- Tight junction integrity was evaluated via immunofluorescence, Western blotting, and RT-PCR.
- Distal colon secretion was measured using Ussing chambers with carbachol and forskolin stimulation.
Main Results:
- Irinotecan induced claudin-1 internalization and ZO-1/occludin proteolysis in wild-type mice, leading to increased intestinal permeability.
- Tlr4-/- mice exhibited preserved tight junction integrity and normal barrier function.
- Baseline conductance and carbachol-induced chloride secretion were elevated in irinotecan-treated wild-type mice, but not in Tlr4-/- mice.
Conclusions:
- TLR4 signaling is critical for irinotecan-induced disruption of intestinal tight junctions, specifically claudin-1 internalization.
- TLR4-dependent mechanisms contribute to increased intestinal permeability and altered colonic secretion, leading to diarrhea.
- Targeting TLR4 may offer a therapeutic strategy to mitigate irinotecan-induced gastrointestinal toxicity.
More Related Videos
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

